Ahmet Yildiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmet Yildiz has a total of 293 co-authors. Here are the top co-authors by number of shared publications:
- Cuneyt Kocas
Department of Cardiology, Istanbul University Institute of Cardiology, Istanbul, Turkey
25 shared publications - Murat Ersanli
Department of Cardiology, Institute of Cardiology, Istanbul University-Cerrahpasa, Istanbul, Turkey
13 shared publications Okay Abaci
Department of Cardiology, Cardiology Institute of Istanbul University-Cerrahpasa, Istanbul, Turkey
12 shared publicationsCem Bostan
Department of Cardiology, Cardiology Institute of Istanbul University-Cerrahpasa, Istanbul, Turkey
11 shared publicationsUgur Coskun
Department of Cardiology, Istanbul University Institute of Cardiology, Istanbul, Turkey
10 shared publications- Ayşem Kaya
Section of Biochemistry, Institute of Cardiology, Istanbul University, Istanbul, Turkey
8 shared publications
Latest Publications
- Open Access
- 4 May 2026
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 51 (5) , 754-761
Evaluation of lysyl oxidase G473A polymorphism with inflammatory cytokines in atherosclerotic coronary artery ectasia patients
Objectives: Coronary artery ectasia (CAE) is characterised by an increase in the diameter of a coronary artery of ≥1.5 times its diameter at the adjacent vessel. It is evident that alterations in the extracellular matrix changes contribute to the development of CAE. Lysyl oxidases (LOXs) are copper-dependent monoamine oxidase enzymes that play a crucial role in the regulation of connective tissue. Deficiencies in these enzymes have been linked to vascular changes, consequently leading to cardiovascular diseases. The objective of this study was to assess the association between the LOX -G473A (rs1800449) variation and inflammatory markers in CAE development. Methods: The current cross-sectional study includes 88 patients whom CAE was confirmed in one of the coronary arteries by coronary angiography and 75 controls with positive exercise tests and angiographically normal coronary arteries without any typical ischemic symptoms and family history of cardiac diseases. Luminex technology was used to detect inflammatory markers. The fluorescence end-point PCR method was used for genotyping. Results: Significantly higher plasma levels of TNF-α, sE-selectin, and hypercholesterolemia were observed in the CAE group (pLOX -G473A polymorphism could be associated with the increase in inflammatory markers and CAE development.
- 4 May 2026
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 51 (5) , 754-761
Open AccessEvaluation of lysyl oxidase G473A polymorphism with inflammatory cytokines in atherosclerotic coronary artery ectasia patients
Objectives: Coronary artery ectasia (CAE) is characterised by an increase in the diameter of a coronary artery of ≥1.5 times its diameter at the adjacent vessel. It is evident that alterations in the extracellular matrix changes contribute to the development of CAE. Lysyl oxidases (LOXs) are copper-dependent monoamine oxidase enzymes that play a crucial role in the regulation of connective tissue. Deficiencies in these enzymes have been linked to vascular changes, consequently leading to cardiovascular diseases. The objective of this study was to assess the association between the LOX -G473A (rs1800449) variation and inflammatory markers in CAE development. Methods: The current cross-sectional study includes 88 patients whom CAE was confirmed in one of the coronary arteries by coronary angiography and 75 controls with positive exercise tests and angiographically normal coronary arteries without any typical ischemic symptoms and family history of cardiac diseases. Luminex technology was used to detect inflammatory markers. The fluorescence end-point PCR method was used for genotyping. Results: Significantly higher plasma levels of TNF-α, sE-selectin, and hypercholesterolemia were observed in the CAE group (pLOX -G473A polymorphism could be associated with the increase in inflammatory markers and CAE development.
- Open Access
- 20 February 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-10
Association between periprocedural cerebral desaturation during transcatheter aortic valve implantation and postprocedural delirium: a prospective observational study
The aim of this study was to investigate whether the level of decrease in cerebral oxygen saturation during the valve placement phase of the transcatheter aortic valve implantation (TAVI) procedure under sedation has an effect on postoperative delirium (POD). The study initially assessed 50 patients between the ages of 50 and 90 years with an indication for TAVI by the cardiac team. Regional cerebral oxygen saturation (rScO2) was measured using Near-infrared spectroscopy (NIRS) before the procedure (T1), during surgical field sterilization (T2), catheter placement (T3), wire manipulation (T4), valve placement (T5) and access site artery repair (T6). Confusion Assessment Method for The Intensive Care Unit (ICU-CAM) test was performed on intensive care unit and the presence of POD was questioned. Patients were divided into two groups as those without POD (Group 1) and those with POD (Group 2). The study was completed with 41 patients in total. While POD was present in 12 (29.3%) of the patients evaluated intensive care unit, POD was not observed in 29 (70.7%) patients. The rScO2 value measured at T5 was significantly lower in Group 2 compared to Group 1 (p < 0.001). In our study, the rate of POD after TAVI was as high as 29.3%. Low rScO2 during valve placement was associated with delirium. Our findings indicate that NIRS devices could be a useful tool for assessing the risk of POD during the TAVI procedure; however, further research is needed to validate their routine clinical use.
- 20 February 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-10
Open AccessAssociation between periprocedural cerebral desaturation during transcatheter aortic valve implantation and postprocedural delirium: a prospective observational study
The aim of this study was to investigate whether the level of decrease in cerebral oxygen saturation during the valve placement phase of the transcatheter aortic valve implantation (TAVI) procedure under sedation has an effect on postoperative delirium (POD). The study initially assessed 50 patients between the ages of 50 and 90 years with an indication for TAVI by the cardiac team. Regional cerebral oxygen saturation (rScO2) was measured using Near-infrared spectroscopy (NIRS) before the procedure (T1), during surgical field sterilization (T2), catheter placement (T3), wire manipulation (T4), valve placement (T5) and access site artery repair (T6). Confusion Assessment Method for The Intensive Care Unit (ICU-CAM) test was performed on intensive care unit and the presence of POD was questioned. Patients were divided into two groups as those without POD (Group 1) and those with POD (Group 2). The study was completed with 41 patients in total. While POD was present in 12 (29.3%) of the patients evaluated intensive care unit, POD was not observed in 29 (70.7%) patients. The rScO2 value measured at T5 was significantly lower in Group 2 compared to Group 1 (p < 0.001). In our study, the rate of POD after TAVI was as high as 29.3%. Low rScO2 during valve placement was associated with delirium. Our findings indicate that NIRS devices could be a useful tool for assessing the risk of POD during the TAVI procedure; however, further research is needed to validate their routine clinical use.
- Open Access
- 14 June 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (4) , 568-577
Joint effects of PPAR G-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation
Objectives: The peroxisome proliferator-activated receptor gamma ( PPARG ) C161T polymorphism (rs3856806) may be a risk factor for in-stent restenosis (ISR) due to its known associations with type 2 diabetes (T2DM), obesity, and coronary artery disease (CAD). This study aims to investigate the relationship between PPARG -C161T polymorphism and the risk of ISR, considering clinical features. Methods: According to the results of coronary angiography, the patients who had undergone drug-eluting stent implantation were categorized into two groups: ISR (n=116) and non-ISR (n=265). The control group consisted of 140 healthy subjects with asymptomatic for CAD or any systemic disease. PPARG -C161T genotypes were determined using the real-time polymerase chain reaction melting curve analysis. Results: T2DM, hypertension, and hyperlipidemia were observed as the main clinical features causing non-ISR and ISR. The 161-CC genotype was associated with an increased risk of ISR compared to both controls (p=0.014) and non-ISR patients (p=0.008). This difference remained statistically significant after multivariate analysis for non-ISR patients (p=0.003) but not for the ISR group. The prevalence of hypertension and hyperlipidemia was higher in ISR patients with T2DM than in non-ISR patients with T2DM (p=0.002 and p=0.009, respectively). Multivariate logistic regression analysis in subgroups based on the presence of T2DM showed that hypertension (pPPARG 161-CC genotype and the risk of ISR, which also means that the PPARG 161-T allele is protective against ISR. However, this effect could be divergent in the presence of the metabolic components of the restenosis phenotype, especially T2DM.
- 14 June 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (4) , 568-577
Open AccessJoint effects of PPAR G-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation
Objectives: The peroxisome proliferator-activated receptor gamma ( PPARG ) C161T polymorphism (rs3856806) may be a risk factor for in-stent restenosis (ISR) due to its known associations with type 2 diabetes (T2DM), obesity, and coronary artery disease (CAD). This study aims to investigate the relationship between PPARG -C161T polymorphism and the risk of ISR, considering clinical features. Methods: According to the results of coronary angiography, the patients who had undergone drug-eluting stent implantation were categorized into two groups: ISR (n=116) and non-ISR (n=265). The control group consisted of 140 healthy subjects with asymptomatic for CAD or any systemic disease. PPARG -C161T genotypes were determined using the real-time polymerase chain reaction melting curve analysis. Results: T2DM, hypertension, and hyperlipidemia were observed as the main clinical features causing non-ISR and ISR. The 161-CC genotype was associated with an increased risk of ISR compared to both controls (p=0.014) and non-ISR patients (p=0.008). This difference remained statistically significant after multivariate analysis for non-ISR patients (p=0.003) but not for the ISR group. The prevalence of hypertension and hyperlipidemia was higher in ISR patients with T2DM than in non-ISR patients with T2DM (p=0.002 and p=0.009, respectively). Multivariate logistic regression analysis in subgroups based on the presence of T2DM showed that hypertension (pPPARG 161-CC genotype and the risk of ISR, which also means that the PPARG 161-T allele is protective against ISR. However, this effect could be divergent in the presence of the metabolic components of the restenosis phenotype, especially T2DM.
- 15 February 2024
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 44 (3) , 185-205
Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions
Recent reports showing that neo-atherosclerosis formation in stented coronary artery is characterized by the accumulation of lipid-laden macrophages within the neointima has strengthened the possibility that elevated low-density lipoprotein (LDL)-cholesterol may be a risk factor for in-stent restenosis (ISR). Protein Convertase Subtilisin/Kexin-9 (PCSK9) protein plays an important role in cholesterol metabolism by degrading of LDL receptors. The gain-of-function E670G (rs505151) mutation of the PCSK9 gene is a well-known genetic risk factor for hypercholesterolemia. This study evaluated for the first time the association of the E670G variation with the serum lipids, PCSK9 levels and concomitant diseases on the ISR risk. The study included 109 ISR, and 82 Non-ISR patients, based on the results of coronary angiography. Genotypes were determined using the real-time PCR and serum PCSK9 levels were measured by ELISA technique. The rare G allele of PCSK9 E670G (p < 0.05), hyperlipidemia (HL) (p < 0.001), and type 2 diabetes (T2DM) (p < 0.01) were associated with increased risk for ISR. In hyperlipidemic conditions, the E670G-G allele was associated with hypercholesterolemia and a higher risk of ISR (p < 0.001), while the E670G-AA genotype has been associated with a high prevalence of T2DM and hypertension. In addition, diabetic ISRs had higher serum PCSK9 levels (p < 0.05) and the E670G-AA genotype was associated with increased levels of diabetes markers. Our results indicated that the unusual effects of both G allele and AA genotype of the PCSK9 E670G variation may be involved in the risk of ISR in association with concomitant metabolic diseases.
- 15 February 2024
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 44 (3) , 185-205
Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions
Recent reports showing that neo-atherosclerosis formation in stented coronary artery is characterized by the accumulation of lipid-laden macrophages within the neointima has strengthened the possibility that elevated low-density lipoprotein (LDL)-cholesterol may be a risk factor for in-stent restenosis (ISR). Protein Convertase Subtilisin/Kexin-9 (PCSK9) protein plays an important role in cholesterol metabolism by degrading of LDL receptors. The gain-of-function E670G (rs505151) mutation of the PCSK9 gene is a well-known genetic risk factor for hypercholesterolemia. This study evaluated for the first time the association of the E670G variation with the serum lipids, PCSK9 levels and concomitant diseases on the ISR risk. The study included 109 ISR, and 82 Non-ISR patients, based on the results of coronary angiography. Genotypes were determined using the real-time PCR and serum PCSK9 levels were measured by ELISA technique. The rare G allele of PCSK9 E670G (p < 0.05), hyperlipidemia (HL) (p < 0.001), and type 2 diabetes (T2DM) (p < 0.01) were associated with increased risk for ISR. In hyperlipidemic conditions, the E670G-G allele was associated with hypercholesterolemia and a higher risk of ISR (p < 0.001), while the E670G-AA genotype has been associated with a high prevalence of T2DM and hypertension. In addition, diabetic ISRs had higher serum PCSK9 levels (p < 0.05) and the E670G-AA genotype was associated with increased levels of diabetes markers. Our results indicated that the unusual effects of both G allele and AA genotype of the PCSK9 E670G variation may be involved in the risk of ISR in association with concomitant metabolic diseases.
- 20 December 2022
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 38 (4) , 248-254
Clinical Features of Patients with Infective Endocarditis in Emergency Department
- 20 December 2022
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 38 (4) , 248-254
Clinical Features of Patients with Infective Endocarditis in Emergency Department
- 3 December 2022
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (2) , 1349-1365
Next-generation sequencing of prolidase gene identifies novel and common variants associated with low prolidase in coronary artery ectasia
Background Decreased collagen biosynthesis and increased collagenolysis can cause ectasia progression in the arterial walls. Prolidase is a key enzyme in collagen synthesis; a decrease in prolidase activity or level may decrease collagen biosynthesis, which may contribute to ectasia formation. Considering that, the variations in PEPD gene encoding prolidase enzyme were evaluated by analyzing next-generation sequencing (NGS) for the first time together with known risk factors in coronary artery ectasia (CAE) patients. Methods Molecular analysis of the PEPD gene was performed on genomic DNA by NGS in 76 CAE patients and 76 controls. The serum levels of prolidase were measured by the sandwich-ELISA technique. Results Serum prolidase levels were significantly lower in CAE group compared to control group, and it was significantly lower in males than females in both groups (p < 0.001). On the other hand, elevated prolidase levels were observed in CAE patients in the presence of diabetes (p < 0.001), hypertension (p < 0.05) and hyperlipidemia (p < 0.05). Logistic regression analysis demonstrated that the low prolidase level (p < 0.001), hypertension (p < 0.02) and hyperlipidemia (p < 0.012) were significantly associated with increased CAE risk. We identified four missense mutations in the PEPD gene, namely G296S, T266A, P365L and S134C (novel) that could be associated with CAE. The pathogenicity of these mutations was predicted to be “damaging” for G296S, S134C and P365L, but “benign” for T266A. We also identified a novel 5′UTR variation (Chr19:34012748 G>A) in one patient who had a low prolidase level. In addition, rs17570 and rs1061338 common variations of the PEPD gene were associated with low prolidase levels in CAE patients, while rs17569 variation was associated with high prolidase levels in both CAE and controls (p < 0.05). Conclusions Our findings indicate that the low serum prolidase levels observed in CAE patients is significantly associated with PEPD gene variations. It was concluded that low serum prolidase level and associated PEPD mutations may be potential biomarkers for the diagnosis of CAE.
- 3 December 2022
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (2) , 1349-1365
Next-generation sequencing of prolidase gene identifies novel and common variants associated with low prolidase in coronary artery ectasia
Background Decreased collagen biosynthesis and increased collagenolysis can cause ectasia progression in the arterial walls. Prolidase is a key enzyme in collagen synthesis; a decrease in prolidase activity or level may decrease collagen biosynthesis, which may contribute to ectasia formation. Considering that, the variations in PEPD gene encoding prolidase enzyme were evaluated by analyzing next-generation sequencing (NGS) for the first time together with known risk factors in coronary artery ectasia (CAE) patients. Methods Molecular analysis of the PEPD gene was performed on genomic DNA by NGS in 76 CAE patients and 76 controls. The serum levels of prolidase were measured by the sandwich-ELISA technique. Results Serum prolidase levels were significantly lower in CAE group compared to control group, and it was significantly lower in males than females in both groups (p < 0.001). On the other hand, elevated prolidase levels were observed in CAE patients in the presence of diabetes (p < 0.001), hypertension (p < 0.05) and hyperlipidemia (p < 0.05). Logistic regression analysis demonstrated that the low prolidase level (p < 0.001), hypertension (p < 0.02) and hyperlipidemia (p < 0.012) were significantly associated with increased CAE risk. We identified four missense mutations in the PEPD gene, namely G296S, T266A, P365L and S134C (novel) that could be associated with CAE. The pathogenicity of these mutations was predicted to be “damaging” for G296S, S134C and P365L, but “benign” for T266A. We also identified a novel 5′UTR variation (Chr19:34012748 G>A) in one patient who had a low prolidase level. In addition, rs17570 and rs1061338 common variations of the PEPD gene were associated with low prolidase levels in CAE patients, while rs17569 variation was associated with high prolidase levels in both CAE and controls (p < 0.05). Conclusions Our findings indicate that the low serum prolidase levels observed in CAE patients is significantly associated with PEPD gene variations. It was concluded that low serum prolidase level and associated PEPD mutations may be potential biomarkers for the diagnosis of CAE.
- Open Access
- 1 May 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (5) , 414-418
TricValve Pop-Out: Management of Transcatheter Caval Valve Migration
- 1 May 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (5) , 414-418
Open AccessTricValve Pop-Out: Management of Transcatheter Caval Valve Migration
- Open Access
- 26 March 2022
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 13 (1) , 29-34
Transkatater aort kapak implantasyonunun böbrek fonksiyonları üzerine etkisi
Amaç: Ciddi Aort Darlığı (AD) olan hastalarda TAVI ,aort kapak obstrüksiyonunu ortadan kaldırarak kardiyak outputu arttırır. Sol ventrikülden çıkan akımın iyileşmesi, böbreklerin kan akımını artırarak renal perfüzyonu artırır ve bozulmuş renal fonksiyonun düzelmesini sağlayabilir. Bunun yanında, TAVI sırasında kontrast madde kullanımına bağlı ya da transfemoral kateterizasyon sırasında aterom plaklarının ve kolesterol kristallerinin saçılması sonucu alt ekstremite veya renal arter embolizasyonuna bağlı akut böbrek yetersizliği gelişebilir. Bu çalışmanın amacı; TAVI’nın böbrek fonksiyonları üzerine 1. aydaki etkisini belirlemek ve hastaların eşlik eden hastalıklarının sonuca etkisi olup olmadığını saptamaktı. Gereç ve Yöntemler:Bu çalışmaya, 2015-2019 yılları arasında ciddi AD ile takip edilip TAVI yapılan toplam 68 hasta dahil edildi. Tüm hastalarda işlem öncesi ve işlemden 1 ay sonra bakılan kreatinin ve GFR değerleri cinsiyete ve eşlik eden hastalıklara göre retrospektif olarak belirlendi ve değerlendirmeler bu temelde yapıldı. Bulgular: Hastaların ortalama yaşı 78.6+7,86, ortalama sol ventrikül ejeksiyon fraksiyonu ise (LVEF ) %56.1+7,82 idi. Mevcut sonuçlar, AD’nIn düzeltilmesinden sonra 1. ayda komorbiditesi bulunan hastaların böbrek fonksiyonlarında düzelme olmadığını aksine ek hastalığı olmayan hastalara göre anlamlı derecede kreatinin değerlerinde artma ve GFR değerinde düşme olduğunu göstermektedir. Diğer komorbidite durumlarının aksine işlem öncesi kronik böbrek hastalığı olanlarda ise 1. ayda kreatinin değerlerinde anlamlı bir artış saptanmamıştır . Sonuç: Çalışmamızda işlem öncesi kronik böbrek hastalığı olan hastalarda böbrek koruması açısından daha titiz olunduğunu ve bu hastalarda kronik böbrek hastalığına sebep olan majör etkenin ciddi AD olması sebebiyle ciddi AD'nın ortadan kalkması ve buna bağlı artan kardiyak debinin böbrek fonksiyonları üzerine olumlu etki yaratarak denge sağladığını düşünüyoruz.
- 26 March 2022
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 13 (1) , 29-34
Open AccessTranskatater aort kapak implantasyonunun böbrek fonksiyonları üzerine etkisi
Amaç: Ciddi Aort Darlığı (AD) olan hastalarda TAVI ,aort kapak obstrüksiyonunu ortadan kaldırarak kardiyak outputu arttırır. Sol ventrikülden çıkan akımın iyileşmesi, böbreklerin kan akımını artırarak renal perfüzyonu artırır ve bozulmuş renal fonksiyonun düzelmesini sağlayabilir. Bunun yanında, TAVI sırasında kontrast madde kullanımına bağlı ya da transfemoral kateterizasyon sırasında aterom plaklarının ve kolesterol kristallerinin saçılması sonucu alt ekstremite veya renal arter embolizasyonuna bağlı akut böbrek yetersizliği gelişebilir. Bu çalışmanın amacı; TAVI’nın böbrek fonksiyonları üzerine 1. aydaki etkisini belirlemek ve hastaların eşlik eden hastalıklarının sonuca etkisi olup olmadığını saptamaktı. Gereç ve Yöntemler:Bu çalışmaya, 2015-2019 yılları arasında ciddi AD ile takip edilip TAVI yapılan toplam 68 hasta dahil edildi. Tüm hastalarda işlem öncesi ve işlemden 1 ay sonra bakılan kreatinin ve GFR değerleri cinsiyete ve eşlik eden hastalıklara göre retrospektif olarak belirlendi ve değerlendirmeler bu temelde yapıldı. Bulgular: Hastaların ortalama yaşı 78.6+7,86, ortalama sol ventrikül ejeksiyon fraksiyonu ise (LVEF ) %56.1+7,82 idi. Mevcut sonuçlar, AD’nIn düzeltilmesinden sonra 1. ayda komorbiditesi bulunan hastaların böbrek fonksiyonlarında düzelme olmadığını aksine ek hastalığı olmayan hastalara göre anlamlı derecede kreatinin değerlerinde artma ve GFR değerinde düşme olduğunu göstermektedir. Diğer komorbidite durumlarının aksine işlem öncesi kronik böbrek hastalığı olanlarda ise 1. ayda kreatinin değerlerinde anlamlı bir artış saptanmamıştır . Sonuç: Çalışmamızda işlem öncesi kronik böbrek hastalığı olan hastalarda böbrek koruması açısından daha titiz olunduğunu ve bu hastalarda kronik böbrek hastalığına sebep olan majör etkenin ciddi AD olması sebebiyle ciddi AD'nın ortadan kalkması ve buna bağlı artan kardiyak debinin böbrek fonksiyonları üzerine olumlu etki yaratarak denge sağladığını düşünüyoruz.
- 8 July 2021
- Published by SAGE Publications in Angiology
- Vol. 73 (2) , 146-151
Long-Term Follow-Up of Patients With Isolated Side Branch Coronary Artery Disease
The data with respect to stable coronary artery disease (SCAD) are mainly confined to main vessel disease. However, there is a lack of information and long-term outcomes regarding isolated side branch disease. This study aimed to evaluate long-term major adverse cardiac and cerebrovascular events (MACCEs) in patients with isolated side branch coronary artery disease (CAD). A total of 437 patients with isolated side branch SCAD were included. After a median follow-up of 38 months, the overall MACCE and all-cause mortality rates were 14.6% and 5.9%, respectively. Among angiographic features, 68.2% of patients had diagonal artery and 82.2% had ostial lesions. In 28.8% of patients, the vessel diameter was ≥2.75 mm. According to the American College of Cardiology lesion classification, 84.2% of patients had either class B or C lesions. Age, ostial lesions, glycated hemoglobin A1c, and neutrophil levels were independent predictors of MACCE. On the other hand, side branch location, vessel diameter, and lesion complexity did not affect outcomes. Clinical risk factors seem to have a greater impact on MACCE rather than lesion morphology. Therefore, the treatment of clinical risk factors is of paramount importance in these patients.
- 8 July 2021
- Published by SAGE Publications in Angiology
- Vol. 73 (2) , 146-151
Long-Term Follow-Up of Patients With Isolated Side Branch Coronary Artery Disease
The data with respect to stable coronary artery disease (SCAD) are mainly confined to main vessel disease. However, there is a lack of information and long-term outcomes regarding isolated side branch disease. This study aimed to evaluate long-term major adverse cardiac and cerebrovascular events (MACCEs) in patients with isolated side branch coronary artery disease (CAD). A total of 437 patients with isolated side branch SCAD were included. After a median follow-up of 38 months, the overall MACCE and all-cause mortality rates were 14.6% and 5.9%, respectively. Among angiographic features, 68.2% of patients had diagonal artery and 82.2% had ostial lesions. In 28.8% of patients, the vessel diameter was ≥2.75 mm. According to the American College of Cardiology lesion classification, 84.2% of patients had either class B or C lesions. Age, ostial lesions, glycated hemoglobin A1c, and neutrophil levels were independent predictors of MACCE. On the other hand, side branch location, vessel diameter, and lesion complexity did not affect outcomes. Clinical risk factors seem to have a greater impact on MACCE rather than lesion morphology. Therefore, the treatment of clinical risk factors is of paramount importance in these patients.